Metal-Salen Complex for Targeted Antitumor Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery methods, particularly for antitumor agents, face challenges in targeting cancer cells effectively, leading to adverse reactions in normal tissues and limiting the dosage due to non-specific distribution, and there is a need for a method to guide drugs precisely to affected sites to enhance therapeutic effects while minimizing side effects.
Innovation Solution
A fluorochrome material based on a metal-salen complex, such as iron-salen, is developed, which can be magnetically guided to target cancer tissues using an external magnetic field and visualized with laser light, with an optimal particle diameter of 2 to 60 µm, preferably 10 µm, to ensure effective targeting and minimize aggregation in blood vessels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antitumor agents are administered to treat cancer, then cancer cells are inhibited, but normal tissues with actively dividing cells suffer adverse reactions
Solution Approach 1:
The patent applies local quality by making the drug delivery system selectively targeted to cancer tissues through magnetic guidance. The metal-salen complex is designed to accumulate specifically at the tumor site under the influence of an external magnetic field, allowing the antitumor agent to exert its effect locally on cancer cells while minimizing exposure to normal tissues. This spatial selectivity resolves the contradiction between achieving antitumor efficacy and avoiding harm to normal actively dividing cells.
Solution Approach 2:
The patent uses a metal-salen complex as an intermediary carrier that combines the antitumor drug with magnetic properties. This intermediary substance can be guided to the tumor site by an external magnetic field and serves as a vehicle to deliver the drug specifically to cancer cells. The intermediary approach allows the drug to reach the affected site through a controlled mechanism, preventing non-specific distribution to normal tissues while maintaining therapeutic effectiveness.
2Productivity
If the dosage of antitumor agents is increased to obtain sufficient pharmacological effects, then cancer treatment effectiveness improves, but adverse reactions in normal tissues intensify
Solution Approach 1:
The metal-salen complex acts as an intermediary that enables precise drug delivery to the tumor site. By using this intermediary carrier with magnetic guidance properties, the system can deliver higher concentrations of antitumor agent specifically to cancer cells without proportionally increasing the overall dosage that would harm normal tissues. The intermediary facilitates the decoupling of therapeutic effect from systemic toxicity.
Solution Approach 2:
The patent achieves local concentration of the antitumor agent at the tumor site through magnetic guidance of the metal-salen complex. This local quality approach allows sufficient pharmacological effect to be achieved at the affected site without requiring high systemic dosages that would cause adverse reactions in normal tissues. The spatial concentration of the drug at the tumor site resolves the contradiction between therapeutic effectiveness and toxicity.
3Ease of operation
If drug delivery is achieved through non-specific distribution, then the drug reaches the affected site, but the concentration at the target site is insufficient
Solution Approach 1:
The metal-salen complex serves as a magnetic intermediary carrier that actively guides the antitumor drug to the tumor site. This intermediary mechanism replaces non-specific distribution with directed transport, enabling the drug to reach the affected site through magnetic guidance. The intermediary approach ensures sufficient drug concentration at the target site while maintaining ease of administration through external magnetic field application.
Solution Approach 2:
The patent replaces non-specific mechanical distribution mechanisms with magnetic field-based guidance. Instead of relying on passive diffusion or blood flow for drug delivery, the system uses an external magnetic field to actively guide the metal-salen complex to the tumor site. This substitution of mechanical distribution with magnetic guidance enables precise targeting and sufficient drug concentration at the affected site.
4Object-affected harmful factors
If the particle diameter of the metal-salen complex is made small to avoid aggregation in blood vessels, then circulation is improved, but magnetic guidance effectiveness is reduced
Solution Approach 1:
The patent optimizes the particle diameter parameter of the metal-salen complex to fall within a specific range (1-100 µm) that balances two opposing requirements: small enough to avoid aggregation in blood vessels and maintain good circulation, but large enough to ensure effective magnetic guidance and accumulation at the tumor site. This parameter optimization resolves the contradiction between circulation safety and magnetic guidance effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The metal-salen complex allows for precise delivery of antitumor drugs to cancer cells, reducing adverse reactions in normal tissues and enhancing the therapeutic effect by concentrating the drug at the target site, while also enabling visualization during surgical removal.
Implementation Method 1
a fluorochrome material based on a metal-salen complex, such as iron-salen, is developed, which can be magnetically guided to target cancer tissues using an external magnetic field
Implementation Method 2
visualized with laser light
Implementation Method 3
a compound whose M is iron emits phosphorescence of microwaves ranging from 300 nm to 500 nm
Data Source
Figure 1
Figure 2
AI summary
It is an object of the present invention to extend the usefulness of an iron-salen complex. The present invention is a new fluorochrome material containing Chemical Formula (I) below. However, M is Fe, Cr, Mn, Co, Ni, Mo, Ru, Rh, Pd, W, Re, Os, Ir, Pt, Nd, Sm, Eu, or Gd. Chemical Formula (I) N,N'-Bis(salicylidene)ethylenediamine metal